Showing results (51-60 of 920) with videos related to
Sort By:
Pageof 92
Bulletin De L'Academie Nationale De Medecine|January 23, 1999
[Heparin-induced thrombopenia: significance and difficulties of precise identification of the immunologic mechanism]M M Samama, I Elalamy, C Lecrubier, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|April 1, 1995
[Hypersensitivity and resistance to antivitamins K]A Keréveur, M Trossaert, M H Horellou, et al.American Journal of Hematology|December 1, 1991
Lupus anticoagulant associated with primary malignant lymphoplasmacytic lymphoma of the spleen: a report of four patientsM Ciaudo, M H Horellou, J Audouin, et al.Haemostasis|October 1, 1996
Diagnosis and clinical characteristics of inherited activated protein C resistanceM M Samama, D Simon, M H Horellou, et al.Journal Des Maladies Vasculaires|January 1, 1982
[Thrombopenia caused by heparin. Review of the literature apropos of a personal case]M Samama, A Kher, M H Horellou, et al.American Journal of Clinical Pathology|October 1, 1995
Prevalence and patient profile in activated protein C resistanceM Samaha, M Trossaert, J Conard, et al.Presse Medicale (Paris, France : 1983)|January 28, 1995
[Resistance to activated protein C in venous thromboembolic complications. Incidence and clinical manifestations]M Trossaërt, J Conard, M H Horellou, et al.Annales Pharmaceutiques Francaises|November 16, 2010
[Two new anticoagulants available in 2010--Dabigatran Etexilate and Rivaroxaban: expected progresses--raised problems]M Samama, J Conard, M-H Horellou, et al.Bulletin De L'Academie Nationale De Medecine|May 1, 1997
[Comparison of two groups of 22 women homozygous or heterozygous for factor V Leiden mutation]M M Samama, J Conard, S Nassiri, et al.Thrombosis and Haemostasis|June 30, 1989
Immunoreactivity of tissue plasminogen activator and of its inhibitor complexes. Biochemical and multicenter validation of a two site immunosorbent assayM Rånby, G Nguyen, P Y Scarabin, et al.Pageof 92